Table 1 Baseline characteristics of patients with breast carcinoma
Indicators | Group A (n = 10) | Group B (n = 10) | P value |
|---|---|---|---|
Mean age (n) | 0.972 | ||
≤60 years | 7 | 7 | |
>60 years | 3 | 3 | |
Lymph node metastasis (n) | 0.881 | ||
0 | 2 | 2 | |
≤3 | 3 | 4 | |
>3 | 5 | 4 | |
Molecular subtypes (n) | 0.639 | ||
Luminal A | 3 | 4 | |
Luminal B | 7 | 6 | |
HER-2 | 0 | 0 | |
Triple negative | 0 | 0 | |
Tumor staging (n) | 0.043 | ||
I | 3 | 0 | |
II | 2 | 7 | |
III | 5 | 3 | |
Tumor size (cm) | <0.001 | ||
≤2 cm | 10 | 2 | |
>2 cm | 0 | 8 | |
Pathological classification (n) | 0.136 | ||
IDC stage I | 0 | 2 | |
IDC stage II | 10 | 8 | |
Poorly differentiated adenocarcinoma | 0 | 0 | |
Adenocarcinoma | 0 | 0 | |
Metastatic adenocarcinoma | 0 | 0 |